Site access drives cost-effectiveness of TAVR, study finds

11/12/2012 | TCTMD.com

The cost-effectiveness of transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis is access-site dependent, according to an analysis of the PARTNER trial published in the Journal of the American College of Cardiology. The findings support the transfemoral route, which demonstrated similar overall costs to surgery but shorter stays in the ICU and hospital overall and shorter procedural time.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX